Shaji Kumar, MD, shares data and insights from the phase 2 RedirecTT-1 study.
Shaji Kumar, MD
Advertisement
Articles by Shaji Kumar, MD
Advertisement
Latest Updated Articles
Dual-Antigen Targeting in Myeloma: Improved Responses in Extramedullary DiseasePublished: June 26th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
ACIP Meeting: COVID-19 Vaccines to be Administered Through Shared Clinical Decision-Making
2
IMS 2025: Advancing Immunotherapy with Costimulatory Bispecific Antibodies in Multiple Myeloma
3
IMS 2025: Daratumumab Plus Lenalidomide Improves Outcomes in Post-Transplant Maintenance for Myeloma
4
Linvoseltamab Plus Carfilzomib Yields Deep, Durable Responses in Patients With RRMM
5
